BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Gedeon Richter Ltd. 

Registered Office
Gyömroi út 19-21
Budapest    H-1103  Hungary
Phone: 36-1-431-4000 Fax: 36-1-260-6650


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. (RIG2.F) Tout Positive Phase 2b Bipolar Depression Data 3/31/2014 6:52:09 AM
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. (RIG2.F) Shows Off Positive Phase 2b Data For Cariprazine To Treat Depression 3/21/2014 7:05:30 AM
Gedeon Richter Ltd. (RIG2.F) Dismisses Rumors Of Potential Takeover By Forest Laboratories, Inc. (FRX) 1/15/2014 6:28:24 AM
Evestra Signs Agreement With Evestra 1/8/2014 9:53:04 AM
FDA Declines To Approve Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd.'s New Antipsychotic Drug 11/21/2013 6:41:02 AM
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. Schizophrenia Drug Meet Phase III Trial Goals 2/28/2012 7:06:24 AM
Forest Laboratories, Inc. (FRX) and Gedeon Richter Ltd. Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder 10/5/2011 6:58:07 AM
Forest Laboratories, Inc. (FRX) and Gedeon Richter Ltd. Announce Results from a Phase II Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder 2/28/2011 9:04:17 AM
Gedeon Richter Ltd. Forms China JV with Marketing Partner 12/22/2010 9:37:54 AM
Watson Pharmaceuticals, Inc. (WPI) and Gedeon Richter Ltd. Announce Exclusive License Agreement with PregLem SA for Esmya(TM); Watson to pay PregLem $17M 12/16/2010 6:39:38 AM
123